TMAM
PBYI icon

Tokio Marine Asset Management’s Puma Biotechnology PBYI Stock Holding History

Tokio Marine Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,500
Closed -$539K – 436
2017
Q1 		$539K Buy
+14,500
New +$529K 0.07% 221

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Tokio Marine Asset Management's PBYI Position: Q2 2017 in Review

Tokio Marine Asset Management sold out of Puma Biotechnology (PBYI) in Q2 2017, closing a stake of 14,500 shares — an estimated $539K sold.

Tokio Marine Asset Management first reported a position in PBYI in Q1 2017 and held it in 1 quarter. The position peaked at $539K in Q1 2017. 154 funds tracked by Wall St. Rank hold PBYI as of Q2 2017.

  • Tokio Marine Asset Management reported no remaining Puma Biotechnology position as of Q2 2017 after selling out during the quarter.
  • Tokio Marine Asset Management sold 14,500 Puma Biotechnology shares in Q2 2017, an estimated $539K.
  • Tokio Marine Asset Management first reported a position in Puma Biotechnology in Q1 2017 and held it in 1 quarter.
  • Tokio Marine Asset Management's Puma Biotechnology position peaked at $539K in Q1 2017.
  • 154 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2017.

Based on Tokio Marine Asset Management's 13F filing for Q2 2017, filed 27 Jul 2017.